Hillhouse Capital Advisors »

Aligos Therapeutics shares owned by Hillhouse Capital Advisors

Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by Hillhouse Capital Advisors from 13F filings

Historical chart of Hillhouse Capital Advisors investment in Aligos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by Hillhouse Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by Hillhouse Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $747k 76k 9.80
2025-06-30 $550k 76k 7.21
2025-03-31 $629k 76k 8.25
2024-12-31 $3.0M 76k 39.84
2024-09-30 $660k 76k 8.66

More positions owned by Hillhouse Capital Advisors

Pdd Holdings Sponsored Ads (PDD)
Alibaba Group Hldg Sponsored Ads (BABA)
Futu Hldgs Spon Ads Cl A (FUTU)
Webull Corp Ord Shs (BULL)
Beone Medicines Sponsored Ads (ONC)
Baidu Spon Adr Rep A (BIDU)
Legend Biotech Corp Sponsored Ads (LEGN)
Netease Sponsored Ads (NTES)
Arrivent Biopharma (AVBP)
Ke Hldgs Sponsored Ads (BEKE)
Full Truck Alliance Sponsored Ads (YMM)
Yatsen Hldg Sponsored Ads (YSG)
Sea Sponsord Ads (SE)
Clearwater Analytics Hldgs I Cl A (CWAN)
Cytek Biosciences (CTKB)

View all positions for Hillhouse Capital Advisors

Top funds holding Aligos Therapeutics

Woodline Partners
Deep Track Capital
Alyeska Investment Group
Sio Capital Management
Readystate Asset Management
Vanguard Group
Adage Capital Partners GP
Baker Bros. Advisors
Hillhouse Capital Advisors
LPL Financial
Renaissance Technologies
Geode Capital Management
Two Sigma Investments
Squarepoint Ops
UBS Group

View all funds holding Aligos Therapeutics